EMD-27637

Single-particle
2.53 Å
EMD-27637
3D View Gallery
Deposition: 15/07/2022
Map released: 19/07/2023
Last modified: 14/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27637

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8dpl summary report (pdf.gz) Map-8dpl FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of EBOV GP lacking the mucin-like domain with 2.1.1D5 scFv and 6D6 scFv bound

EMD-27637

Single-particle
2.53 Å
EMD-27637
3D View Gallery
Deposition: 15/07/2022
Map released: 19/07/2023
Last modified: 14/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Ebola virus - Mayinga, Zaire, 1976, Homo sapiens, Mus musculus
Sample: Structure of EBOV GP in complex with 2.1.1D5 scFv and 6D6 scFv
Fitted models: 8dpl

Deposition Authors: Yu X, Saphire EO
The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus.
Yu X, Hastie KM, Davis CW, Avalos RD, Williams D, Parekh D, Hui S , Mann C, Hariharan C, Takada A, Ahmed R, Saphire EO
(2023) Cell Rep , 42 , 113366 - 113366
PUBMED: 37938974
DOI: doi:10.1016/j.celrep.2023.113366
ISSN: 2211-1247